How Pharmaceutical Industry Employees Manage Competing Moral Commitments

Lipworth, Wendy; Montgomery, Kathleen; Little, Miles

doi:10.5465/ambpp.2013.10048abstract

Cited by 2 publications

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Like clinicians and researchers, industry employees (at least those in medical and regulatory departments) are concerned about doing good, not doing harm and achieving justice, both for their companies and for the general public (Lipworth and Little, 2014). They also have a variety of sophisticated ways of working through competing commercial and medical or scientific goals (Lipworth, Montgomery, and Little, 2013). This suggests that there would be ways for those with concerns about the pharmaceutical industry to engage more with employees of pharmaceutical companies.…”

Section: Addressing Ambivalencementioning

confidence: 99%

Inter-Organizational Networks in Health Care

Sheaff¹,

Schofield²

2016

Oxford Handbooks Online

View full text Add to dashboard Cite

Inter-organizational networks have proliferated in health systems, as has network research, but coherent explanations relating the varieties of health network to their respective structures, activities and outcomes remain lacking. Focusing on their core productive processes and their governance structures, this chapter contrasts care networks with program networks. It compares these concepts with findings from some primary research on NHS health networks during 2005–10, and notes some implications for network theory and research. NHS networks’ dense, flat structures reflect these networks’ dual function as both care and as program networks. These findings are relevant to the “integrated care” networks developing in many health systems. The development of these networks appears, partly, to be a workaround for the obstacles that market and quasi-market health systems place in the way of coordinating complex care across multiple separate providers.

show abstract

Section: Addressing Ambivalencementioning

confidence: 99%

Inter-Organizational Networks in Health Care

Sheaff¹,

Schofield²

2016

Oxford Handbooks Online

View full text Add to dashboard Cite

show abstract

Pharmaceuticals, Money, and the Health Care Organizational Field

Lipworth

2016

Oxford Handbooks Online

View full text Add to dashboard Cite

Using an institutional theory framework, this chapter discusses the place of the pharmaceutical industry within the health care organizational field, and the wide-ranging effects the industry has on the other organizations in the field. It then provides a snapshot of the discourse that has emerged about the pharmaceutical industry, and about commercialization and marketization of the health care more generally. This paints a picture of deep ambivalence toward the pharmaceutical industry, both within and between stakeholder groups. The chapter ends with an effort to explain this ambivalence as the effect of competing institutional logics. This, in turn, points to some suggestions as to how the pharmaceutical industry might be better accommodated within the health care organizational field, without losing sight of the need for ongoing critique of industry behavior.

show abstract

How Pharmaceutical Industry Employees Manage Competing Moral Commitments

Cited by 2 publications

References 32 publications

Inter-Organizational Networks in Health Care

Inter-Organizational Networks in Health Care

Pharmaceuticals, Money, and the Health Care Organizational Field

Contact Info

Product

Resources

About